Changchun Intellicrown Pharmaceutical Co. LTD
4 clinical trials · Sponsor
◉ Watch Changchun Intellicrown Pharmaceutical Co. LTD
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH (NCT07016633) | Changchun Intellicrown Pharmaceutical Co. LTD | 2025-06-10 |
| ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies (NCT04412616) | Changchun Intellicrown Pharmaceutical Co. LTD | 2020-09-01 |
| Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors (NCT04126590) | Changchun Intellicrown Pharmaceutical Co. LTD | 2020-01-09 |
Track Changchun Intellicrown Pharmaceutical Co. LTD automatically
Every clearance here is in the API, with alerts when new ones post.